Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HEMA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHEMAHemaCare$25.31+0.6%$25.31$8.62▼$26.23$346.52M1.4739,950 shs5,400 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHEMAHemaCare0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHEMAHemaCare$25.31+0.6%$25.31$8.62▼$26.23$346.52M1.4739,950 shs5,400 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHEMAHemaCare0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHEMAHemaCare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHEMAHemaCareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHEMAHemaCareN/AN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHEMAHemaCareN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHEMAHemaCareN/AInsider OwnershipCompanyInsider OwnershipHEMAHemaCare26.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHEMAHemaCareN/A13.69 millionN/ANot OptionableHEMA HeadlinesRecent News About These CompaniesAutoimmune Disease Diagnostics Market Outlook, Innovations, Key Drivers, and Forecast (2024-2032)November 12, 2024 | taiwannews.com.twTApheresis Equipment Market Forecast, Advancements, Demand Drivers, and Global Outlook (2024-2032)November 12, 2024 | taiwannews.com.twTGlobal Leukapheresis Products Market Set to Reach USD 2.1 Billion by 2033, Driven by Rising Cancer Cases and Technological Advances | FMINovember 4, 2024 | fmiblog.comFBone Marrow Transplant Market to Reach USD 14.86 Billion by 2033 at a 3.4% of CAGROctober 15, 2024 | fmiblog.comFGlobal Cell Freezing Media Market Size To Worth USD 387.5 Million By 2033 l CAGR Of 9.66%July 19, 2024 | finance.yahoo.comGlobal Bone Marrow Transplant IndustryMay 27, 2024 | fmiblog.comFApheresis Market Forecast: Expected Growth and Trends in Coming YearsMay 9, 2024 | taiwannews.com.twTDonors flock to blood centers following Union Station shootingFebruary 21, 2024 | msn.comLeukapheresis Market size worth $ 100647.54 Million, Globally, by 2028 at 6.08% CAGR: Verified Market Research®November 7, 2023 | prnewswire.co.ukPHEMA Historical DataOctober 22, 2023 | investing.comPlasmapheresis Periprocedural Care Equipments Market Is Likely to Grasp the CAGR of 5.20% By 2029October 3, 2023 | pharmiweb.comPPrimary Cells Market worth $2.8 billion | MarketsandMarketsJuly 6, 2023 | finanznachrichten.deThe worldwide Therapeutic Plasma Exchange industry is currently experiencing significant growth and expanding at a 13.6% CAGR from 2023 - 2030June 22, 2023 | marketwatch.comPowering Hope: Bone Marrow Transplantation Market Set to Grow at a Robust CAGR of 3.7% through 2023-2028| HemaCare, ReeLabs Pvt. Ltd.June 7, 2023 | medgadget.comPrimary Hepatocytes Market Set to Skyrocket with a Staggering CAGR of 6.6% by 2023-2032| Lonza, Corning Inc.June 6, 2023 | medgadget.comRegion-Wise Apheresis Machines Market Analysis Forecast 2023-2030May 16, 2023 | marketwatch.com2023 Apheresis Machines Market Price & News with Size Forecast 2030May 14, 2023 | marketwatch.comPeripheral Blood Market upto 2030May 14, 2023 | marketwatch.com2023 Bone Marrow Transplant Market: Trends and Forecast 2031 | A Detailed Sales Channel Analysis ReportMay 8, 2023 | marketwatch.comResearch Use Human Cells Market 2023 Size, Status and Global Outlook -Charles River, Lonza, Thermo Fisher Scientific, Sigma-AldrichMay 4, 2023 | marketwatch.comHEMA Company DescriptionsHemaCare OTCMKTS:HEMA$25.31 +0.15 (+0.60%) As of 01/3/2020HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
